VSTM Q3 2021 Earnings — Verastem, Inc. Revenue & Financial Results | Market Cap Arena

VSTMVerastem, Inc.

$376M

Q3 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2,000-100.0% YoY

Gross Profit

$2,000100.0% margin

Operating Income

-$15M-742300.0% margin

Net Income

-$23M-1139300.0% margin

EPS (Diluted)

$-1.52

QoQ Revenue Growth

-99.6%

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$11M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$112M

Total Liabilities

$16M

Stockholders' Equity

$96M

Cash & Equivalents

$24M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2,000	$79M	-100.0%
Gross Profit	$2,000	$47M	-100.0%
Operating Income	-$15M	$15M	-198.9%
Net Income	-$23M	$13M	-273.4%

Revenue Segments

Transition Services Revenue

$2,000100%